華裔研究員巧妙構(gòu)建新融合蛋白,解決粘膜疫苗傳輸問題(3)
2011-02-16 09:58
閱讀:1925
來源:生物通
作者:大*勒
責(zé)任編輯:大彌勒
[導(dǎo)讀] 來自美國馬里蘭大學(xué)的研究人員巧妙的構(gòu)建了一種新型的融合蛋白,解決了粘膜疫苗的關(guān)鍵傳輸問題,并提出了一種可以簡化粘膜疫苗的制備,分配及傳遞過程的新策略,這一研究成果公布在Nature Biotechnology雜志上。 文章的通訊作者是馬里蘭大學(xué)華裔學(xué)者朱小平副
原文摘要:
Efficient mucosal vaccination mediated by the neonatal Fc receptor
Almost all infectious diseases are initiated at mucosal surfaces, yet intramuscular or subcutaneous vaccination usually provides only minimal protection at sites of infection owing to suboptimal activation of the mucosal immune system. The neonatal Fc receptor (FcRn) mediates the transport of IgG across polarized epithelial cells lining mucosal surfaces. We mimicked this process by fusing a model antigen, herpes simplex virus type-2 (HSV-2) glycoprotein gD, to an IgG Fc fragment. Intranasal immunization, together with the adjuvant CpG, completely protected wild-type, but not FcRn knockout, mice after intravaginal challenge with virulent HSV-2 186. This immunization strategy induced efficient mucosal and systemic antibody, B- and T-cell immune responses, with stable protection for at least 6 months after vaccination in most of the immunized animals. The FcRn-IgG transcellular transport pathway may provide a general delivery route for subunit vaccines against many mucosal pathogens.